SMTL ID : 6zov.4 (3 other biounits)

ENTEROPEPTIDASE IN COMPLEX WITH COMPOUND 6

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.19 Å

Oligo State

monomer

Ligands

1 x GBS: 4-carbamimidamidobenzoic acid(Covalent)

GBS.1: 13 residues within 4Å: Chain A: D.181, S.182, C.183, Q.184, G.185, S.187, T.205, S.206, F.207, G.208, E.210, C.211, G.218 8 PLIP interactions: 8 interactions with chain A Hydrophobic interactions: A:T.205 Hydrogen bonds: A:S.182, A:G.185, A:S.187, A:E.210 Water bridges: A:S.182, A:Y.209 Salt bridges: A:D.181

2 x EDO: 1,2-ETHANEDIOL(Non-functional Binders)

EDO.2: 4 residues within 4Å: Chain A: V.71, R.73, N.103, T.105 3 PLIP interactions: 3 interactions with chain A Hydrogen bonds: A:R.73, A:R.73, A:N.103 EDO.3: 3 residues within 4Å: Chain A: N.154, E.168, R.222 No protein-ligand interaction detected (PLIP)

1 x GOL: GLYCEROL(Non-functional Binders)

GOL.4: 5 residues within 4Å: Chain A: H.83, N.91, N.169, R.225, F.226 6 PLIP interactions: 6 interactions with chain A Hydrogen bonds: A:N.91, A:R.225 Water bridges: A:N.81, A:H.83, A:N.169, A:N.169

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Sun, W. et al., Targeting Enteropeptidase with Reversible Covalent Inhibitors To Achieve Metabolic Benefits. J.Pharmacol.Exp.Ther. (2020)

Release Date

2020-10-21

Peptides

Enteropeptidase: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
D

Enteropeptidase

Related Entries With Identical Sequence